Login / Signup
Andrea Favre-Bulle
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Epidermal Growth Factor Receptor
Advanced Non Small Cell Lung Cancer
Smoking Cessation
Top Venues
Journal of medical economics
PharmacoEconomics - open
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Andrea Favre-Bulle
,
Goran Bencina
,
Shujing Zhang
,
Ruixuan Jiang
,
Daniel Andritschke
,
Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.
Journal of medical economics
(2023)
Andrea Favre-Bulle
,
Goran Bencina
,
Shujing Zhang
,
Ruixuan Jiang
,
Daniel Andritschke
,
Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.
Journal of medical economics
(2023)
Andrea Favre-Bulle
,
Min Huang
,
Amin Haiderali
,
Arjun Bhadhuri
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland.
PharmacoEconomics - open
(2023)
Andrea Favre-Bulle
,
Goran Bencina
,
Shujing Zhang
,
Ruixuan Jiang
,
Daniel Andritschke
,
Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.
Journal of medical economics
26 (1) (2023)